• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫细胞中的蛋白酶体:不仅仅是肽类产物?

Proteasomes in immune cells: more than peptide producers?

机构信息

Division of Immunology, Department of Biology, University of Constance, Konstanz, Germany.

出版信息

Nat Rev Immunol. 2010 Jan;10(1):73-8. doi: 10.1038/nri2687. Epub 2009 Dec 11.

DOI:10.1038/nri2687
PMID:20010787
Abstract

When cells are stimulated with pro-inflammatory cytokines, most of their constitutively expressed proteasomes are replaced with immunoproteasomes, which increase the production of peptides for presentation on MHC class I molecules. In addition, cortical thymic epithelial cells selectively express a type of proteasome known as the thymoproteasome that is required for the positive selection of thymocytes. Here, we discuss how these specialized types of proteasome shape the T cell receptor repertoire of cytotoxic T lymphocytes and propose that immunoproteasomes have functions, in addition to antigen processing, that influence cytokine production and T cell differentiation, survival and function. We also discuss how inhibitors of immunoproteasomes can suppress undesired T cell responses in autoimmune diseases.

摘要

当细胞受到促炎细胞因子刺激时,它们大多数组成型表达的蛋白酶体被免疫蛋白酶体取代,这增加了用于 MHC Ⅰ类分子呈递的肽的产生。此外,皮质胸腺上皮细胞选择性表达一种称为胸腺蛋白酶体的蛋白酶体,这是胸腺细胞阳性选择所必需的。在这里,我们讨论了这些专门类型的蛋白酶体如何塑造细胞毒性 T 淋巴细胞的 T 细胞受体库,并提出免疫蛋白酶体除了抗原加工外,还具有影响细胞因子产生和 T 细胞分化、存活和功能的功能。我们还讨论了免疫蛋白酶体抑制剂如何抑制自身免疫性疾病中不希望出现的 T 细胞反应。

相似文献

1
Proteasomes in immune cells: more than peptide producers?免疫细胞中的蛋白酶体:不仅仅是肽类产物?
Nat Rev Immunol. 2010 Jan;10(1):73-8. doi: 10.1038/nri2687. Epub 2009 Dec 11.
2
The role of the proteasome in the generation of MHC class I ligands and immune responses.蛋白酶体在 MHC I 类配体产生和免疫反应中的作用。
Cell Mol Life Sci. 2011 May;68(9):1491-502. doi: 10.1007/s00018-011-0657-y. Epub 2011 Mar 9.
3
Thymoproteasome and peptidic self.胸腺蛋白酶体和肽段自身。
Immunogenetics. 2019 Mar;71(3):217-221. doi: 10.1007/s00251-018-1081-3. Epub 2018 Oct 15.
4
Thymoproteasome shapes immunocompetent repertoire of CD8+ T cells.胸腺蛋白酶体塑造 CD8+ T 细胞的免疫应答库。
Immunity. 2010 Jan 29;32(1):29-40. doi: 10.1016/j.immuni.2009.10.009. Epub 2009 Dec 31.
5
The Role of Proteasomes in the Thymus.蛋白酶体在胸腺中的作用。
Front Immunol. 2021 Mar 19;12:646209. doi: 10.3389/fimmu.2021.646209. eCollection 2021.
6
Origin and evolution of the specialized forms of proteasomes involved in antigen presentation.参与抗原呈递的蛋白酶体特殊形式的起源和进化。
Immunogenetics. 2019 Mar;71(3):251-261. doi: 10.1007/s00251-019-01105-0. Epub 2019 Jan 24.
7
Tissue-specific proteasomes in generation of MHC class I peptides and CD8 T cells.组织特异性蛋白酶体在 MHC Ⅰ类肽和 CD8 T 细胞生成中的作用。
Curr Opin Immunol. 2022 Aug;77:102217. doi: 10.1016/j.coi.2022.102217. Epub 2022 Jun 8.
8
Role of immunoproteasomes and thymoproteasomes in health and disease.免疫蛋白酶体和胸腺蛋白酶体在健康和疾病中的作用。
Pathol Int. 2021 Jun;71(6):371-382. doi: 10.1111/pin.13088. Epub 2021 Mar 3.
9
Thymoproteasome: role in thymic selection and clinical significance as a diagnostic marker for thymic epithelial tumors.胸腺蛋白酶体:在胸腺选择中的作用及其作为胸腺瘤诊断标志物的临床意义。
Arch Immunol Ther Exp (Warsz). 2013 Oct;61(5):357-65. doi: 10.1007/s00005-013-0234-1. Epub 2013 May 7.
10
MHC class I antigen processing of an adenovirus CTL epitope is linked to the levels of immunoproteasomes in infected cells.腺病毒细胞毒性T淋巴细胞表位的MHC I类抗原加工与感染细胞中免疫蛋白酶体的水平相关。
J Immunol. 2000 May 1;164(9):4500-6. doi: 10.4049/jimmunol.164.9.4500.

引用本文的文献

1
Proteasome dysfunction in T cells causes immunodeficiency via cell cycle disruption and apoptosis.T细胞中的蛋白酶体功能障碍通过细胞周期紊乱和细胞凋亡导致免疫缺陷。
Int Immunol. 2025 Jul 22;37(8):493-505. doi: 10.1093/intimm/dxaf021.
2
The Thymus as a Mirror of the Body's Gene Expression.胸腺作为身体基因表达的一面镜子。
Adv Exp Med Biol. 2025;1471:247-268. doi: 10.1007/978-3-031-77921-3_9.
3
Immunoproteasome subunits are novel signatures for predicting efficacy of immunotherapy in muscle invasive bladder cancer.免疫蛋白酶体亚基是预测肌肉浸润性膀胱癌免疫治疗疗效的新标志物。

本文引用的文献

1
Critical role for the immunoproteasome subunit LMP7 in the resistance of mice to Toxoplasma gondii infection.免疫蛋白酶体亚基 LMP7 在小鼠抵抗弓形虫感染中的关键作用。
Eur J Immunol. 2009 Dec;39(12):3385-94. doi: 10.1002/eji.200839117.
2
A selective inhibitor of the immunoproteasome subunit LMP7 blocks cytokine production and attenuates progression of experimental arthritis.免疫蛋白酶体亚基LMP7的选择性抑制剂可阻断细胞因子的产生并减缓实验性关节炎的进展。
Nat Med. 2009 Jul;15(7):781-7. doi: 10.1038/nm.1978. Epub 2009 Jun 14.
3
Recognition and processing of ubiquitin-protein conjugates by the proteasome.
J Transl Med. 2025 Feb 26;23(1):228. doi: 10.1186/s12967-025-06207-w.
4
Recent Advances in the Development of Immunoproteasome Inhibitors as Anti-Cancer Agents: The Past 5 Years.免疫蛋白酶体抑制剂作为抗癌药物的研发新进展:过去五年
Molecules. 2025 Feb 6;30(3):755. doi: 10.3390/molecules30030755.
5
Mitochondrial protein import stress.线粒体蛋白输入应激
Nat Cell Biol. 2025 Feb;27(2):188-201. doi: 10.1038/s41556-024-01590-w. Epub 2025 Jan 22.
6
Thymic and T-cell intrinsic critical roles associated with severe combined immunodeficiency and Omenn syndrome due to a heterozygous variant (G201R) in PSMB10.由于PSMB10基因杂合变异(G201R)导致的严重联合免疫缺陷和奥门综合征相关的胸腺和T细胞内在关键作用。
J Allergy Clin Immunol. 2025 Apr;155(4):1378-1385.e2. doi: 10.1016/j.jaci.2024.12.1082. Epub 2024 Dec 27.
7
The Novel HDAC Inhibitor OBP-801 Promotes MHC Class I Presentation Through LMP2 Upregulation, Enhancing the PD-1-Targeting Therapy in Clear Cell Renal Cell Carcinoma.新型组蛋白去乙酰化酶抑制剂OBP-801通过上调LMP2促进MHC I类分子提呈,增强透明细胞肾细胞癌的PD-1靶向治疗。
Cancers (Basel). 2024 Dec 4;16(23):4058. doi: 10.3390/cancers16234058.
8
Discovery of Novel Nonpeptidic Proteasome Inhibitors Using Covalent Virtual Screening and Biological Evaluation.利用共价虚拟筛选和生物学评价发现新型非肽类蛋白酶体抑制剂
ACS Med Chem Lett. 2024 Sep 9;15(10):1741-1748. doi: 10.1021/acsmedchemlett.4c00321. eCollection 2024 Oct 10.
9
Proximity-dependent labeling identifies dendritic cells that drive the tumor-specific CD4 T cell response.邻近依赖性标记鉴定出驱动肿瘤特异性 CD4 T 细胞反应的树突状细胞。
Sci Immunol. 2024 Oct 4;9(100):eadq8843. doi: 10.1126/sciimmunol.adq8843.
10
Synthesis and Application of a Versatile Immunoproteasome Activity Probe.一种通用免疫蛋白酶体活性探针的合成与应用
Chembiochem. 2024 Dec 2;25(23):e202400571. doi: 10.1002/cbic.202400571. Epub 2024 Nov 12.
蛋白酶体对泛素-蛋白质缀合物的识别与加工。
Annu Rev Biochem. 2009;78:477-513. doi: 10.1146/annurev.biochem.78.081507.101607.
4
Exclusive expression of proteasome subunit {beta}5t in the human thymic cortex.蛋白酶体亚基β5t在人胸腺皮质中的特异性表达。
Blood. 2009 May 21;113(21):5186-91. doi: 10.1182/blood-2008-11-187633. Epub 2009 Mar 16.
5
Development of proteasome inhibitors in oncology and autoimmune diseases.蛋白酶体抑制剂在肿瘤学和自身免疫性疾病中的发展。
Curr Opin Drug Discov Devel. 2008 Sep;11(5):616-25.
6
Thymoproteasome: probable role in generating positively selecting peptides.胸腺蛋白酶体:在产生阳性选择肽方面的可能作用。
Curr Opin Immunol. 2008 Apr;20(2):192-6. doi: 10.1016/j.coi.2008.03.002. Epub 2008 Apr 9.
7
The biological functions of T helper 17 cell effector cytokines in inflammation.辅助性T细胞17效应细胞因子在炎症中的生物学功能
Immunity. 2008 Apr;28(4):454-67. doi: 10.1016/j.immuni.2008.03.004.
8
The proteasome immunosubunit multicatalytic endopeptidase complex-like 1 is a T-cell-intrinsic factor influencing homeostatic expansion.蛋白酶体免疫亚基多催化内肽酶复合物样1是一种影响稳态扩增的T细胞内在因子。
Infect Immun. 2008 Mar;76(3):1207-13. doi: 10.1128/IAI.01134-07. Epub 2007 Dec 26.
9
Regulation of CD8+ T cell development by thymus-specific proteasomes.胸腺特异性蛋白酶体对CD8 + T细胞发育的调控。
Science. 2007 Jun 1;316(5829):1349-53. doi: 10.1126/science.1141915.
10
The final touches make perfect the peptide-MHC class I repertoire.最后的修饰使肽 - 主要组织相容性复合体I类库臻于完美。
Immunity. 2007 Apr;26(4):397-406. doi: 10.1016/j.immuni.2007.04.003.